310 related articles for article (PubMed ID: 31153143)
1. Management trends for anaplastic meningioma with adjuvant radiotherapy and predictors of long-term survival.
Alhourani A; Aljuboori Z; Yusuf M; Woo SY; Hattab EM; Andaluz N; Williams BJ
Neurosurg Focus; 2019 Jun; 46(6):E4. PubMed ID: 31153143
[TBL] [Abstract][Full Text] [Related]
2. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
3. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
[TBL] [Abstract][Full Text] [Related]
4. Trends in the utilization of radiotherapy for spinal meningiomas: insights from the 2004-2015 National Cancer Database.
Yolcu YU; Goyal A; Alvi MA; Moinuddin FM; Bydon M
Neurosurg Focus; 2019 Jun; 46(6):E6. PubMed ID: 31153154
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
6. Major complications from radiotherapy following treatment for atypical meningiomas.
Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
[TBL] [Abstract][Full Text] [Related]
7. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Adeberg S; Hartmann C; Welzel T; Rieken S; Habermehl D; von Deimling A; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):859-64. PubMed ID: 22137023
[TBL] [Abstract][Full Text] [Related]
9. Primary management of atypical meningioma: treatment patterns and survival outcomes by patient age.
Barthélemy E; Loewenstern J; Konuthula N; Pain M; Hall J; Govindaraj S; Bederson J; Shrivastava RK
J Cancer Res Clin Oncol; 2018 May; 144(5):969-978. PubMed ID: 29500705
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
11. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
Patibandla MR; Lee CC; Tata A; Addagada GC; Sheehan JP
J Neurosurg; 2018 Nov; 129(5):1249-1259. PubMed ID: 29303453
[TBL] [Abstract][Full Text] [Related]
13. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
Orton A; Frandsen J; Jensen R; Shrieve DC; Suneja G
J Neurosurg; 2018 Jun; 128(6):1684-1689. PubMed ID: 28731397
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
16. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
18. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
[TBL] [Abstract][Full Text] [Related]
19. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
